BioSqueeze
Butte, US · Founded 2021 · Delaware corporation · 38 employees on LinkedIn · 3 known investors
BioSqueeze develops well integrity solutions for the oil and gas industry, using biomineralization technology to seal cement gaps and leaks in wells. The company offers multiple sealing products (MicroSeal, MacroSeal, NanoSeal) and diagnostic services for well remediation and decommissioning.
Also known as BioSqueeze Inc.
Founders & leadership
Investors · 3
Reported raises · per SEC filings
Form D private placements$13.5M disclosed across 2 rounds · 2021–2023
▶$9.4MraisedMay 2023 · 9 investors · Other TechnologyRule 506(b)
- Kristen SuddathDirector
- Dwight HiebertDirector
- Subodh GuptaDirector
- Mark RanalliExecutive Officer, Director
- Offering amount
- $9.4M
- Amount sold
- $9.4M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$4.1MraisedSep 2021 · 37 investors · Other TechnologyRule 506(b)
- Latham TurnerDirector
- Mark RanalliExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026BioSqueeze is a biomineralization platform company focused on difficult subsurface engineering problems. Its technology is delivered as a low-viscosity liquid system that penetrates pores, fractures and void spaces that bulk materials such as cement cannot reach, then mineralizes in place through a controlled process that forms structural limestone.
The company frames its platform around three engineering functions: strengthening soils and unconsolidated materials to increase bearing capacity, sealing fluid pathways and reducing permeability to eliminate leakage, and healing fractures and aging concrete or cementitious infrastructure. Rather than positioning around a single vertical, BioSqueeze targets recurring subsurface conditions — complex geology, groundwater movement, fractures, unstable soils and aging infrastructure — across energy, defense, mining, infrastructure and environmental applications.
BioSqueeze publishes case studies and technical papers documenting well-integrity challenges, treatment design and field outcomes, and describes a multidisciplinary team spanning engineering, field operations, biological systems, manufacturing, defense programs and commercial development.
Traction
BioSqueeze reports over 400 field deployments, more than 55 customer master service agreements, over $10 million in U.S. Department of Defense development funding, and activity across five major infrastructure markets.
▸Full profile — market position, technology, go-to-market, geography
Market position
BioSqueeze positions its platform as an alternative where conventional placement materials reach their limits — where access is constrained, geology is complex, or permanent subsurface control is required.
Technology
The core technology is a biomineralization delivery system. Low-viscosity fluids are injected so they enter pores, fractures and void spaces, reaching pathways that conventional bulk materials often cannot access. A controlled mineralization process then forms structural limestone in place, producing permanent sealing, reinforcement or repair of the treated zone.
Go-to-market
The company sells directly through master service agreements with customers and engages prospects around specific applications, supporting sales with a technical resource library of case studies and published papers documenting field outcomes.
Operators and engineers working on subsurface and infrastructure problems in five markets: energy, defense, mining, infrastructure and environmental systems, including well-integrity work. The company reports more than 55 customer master service agreements.
Geography
Headquartered in Butte, Montana, United States.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlap
Companies competing with BioSqueeze for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2023 | $1.2M |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2022 | $4M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- BioSqueezebiosqueeze.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does BioSqueeze do?
- BioSqueeze is a biomineralization platform company that seals, strengthens and repairs subsurface formations and infrastructure.
- Who are BioSqueeze's investors?
- BioSqueeze's investors include Next Frontier Capital, Zero Infinity Partners, Overture Climate.
- How much funding has BioSqueeze raised?
- BioSqueeze has disclosed $13.5M raised across 2 rounds.
- Where is BioSqueeze headquartered?
- BioSqueeze is headquartered in Butte, US.